CerviLenz Debuts Simple Device to Assess Preterm Labor

medGadget, May 18, 2010

Out of Cleveland, OH, CerviLenz has debut a device for preterm labor triage based on intravaginal measurements of cervical length taken during pregnancy. Revealed this week at the American College of Obstetricians and Gynecologists (ACOG) meeting held in San Francisco, the simple device can also be used to monitor a patient’s risk for preterm labor. CerviLenz is FDA cleared and clinical trials are underway.

From the announcement:

CerviLenz helps obstetricians, nurse-midwives, and L&D nurses assess and monitor women with signs or symptoms of preterm labor. Any health care professional trained to use a speculum can use CerviLenz. With accurate and immediate results, clinicians can make confident decisions faster. Using CerviLenz in the standard workup helps hospitals reduce costs and increase efficiency while improving patient care.

Today at the Annual Meeting of The American College of Obstetricians and Gynecologists, Dr. Richard Burwick of Harbor-UCLA Medical Center in Los Angeles, CA, presented data from a new study on CerviLenz® – an innovative device used to measure vaginal cervical length in pregnant women.

The study found that a CerviLenz measurement of 30 mm was equivalent to the fetal fibronectin test (Hologic, Inc.) in predicting preterm birth in women with signs and symptoms of preterm labor.

Product page…

Press releases below the fold:

“NEW TOOL FOR PRETERM LABOR TRIAGE TO BE INTRODUCED AT ACOG ANNUAL CLINICAL MEETING”

SAN FRANCISCO, CA, May 15, 2010:

CerviLenz Inc. announces the availability of its innovative device, CerviLenz® – a new tool for preterm labor triage. CerviLenz measures vaginal cervical length objectively, the first and only device of its kind.

CerviLenz helps obstetricians, nurse-midwives, and L&D nurses assess and monitor women with signs or symptoms of preterm labor. Any health care professional trained to use a speculum can use CerviLenz. With accurate and immediate results, clinicians can make confident decisions faster. Using CerviLenz in the standard workup helps hospitals reduce costs and increase efficiency while improving patient care.

Hospital Labor & Delivery Units are often overwhelmed with cases of suspected preterm labor. A quantifiable and reliable measurement of vaginal cervical length allows quick assessment of whether delivery is imminent and what level of care is necessary.

Dr. Michael Ross, Medical Director of CerviLenz Inc. and a Board Certified Maternal-Fetal Medicine specialist explained that “Evaluating cervical length and any cervical change over time is well-established as critical in determining preterm birth risk. A CerviLenz measurement adds significant clinical value to preterm labor triage. Until now, clinicians in Labor & Delivery have only been able to estimate vaginal cervical length subjectively with a digital exam. CerviLenz gives clinicians an objective evaluation right away. Moreover, using CerviLenz in the standard triage workup for symptomatic patients speeds decision-making. Helping clinicians determine which patients require admission and guiding more selective use of resources such as transvaginal ultrasound or the fetal fibronectin test, CerviLenz helps provide efficient, cost-effective, high quality care.”

Dean Koch, President and CEO of CerviLenz Inc. said, “We are thrilled to bring CerviLenz to market to support clinicians with new, clinically relevant, objective information. To help hospitals put CerviLenz into practice quickly and easily, CerviLenz Inc. will provide a comprehensive yet simple training program. From high-risk centers to community hospitals, we are confident that CerviLenz will positively impact care for pregnant women in the stressful situation of suspected preterm labor.”

CerviLenz Inc. is the manufacturer and distributor of CerviLenz®. CerviLenz Inc. is dedicated to making a difference in the world of prematurity and donates a portion of revenue to charitable organizations advancing maternal and fetal health worldwide.

————————————————————–

“IMPORTANT DATA ON CERVILENZ A NEW TOOL TO HELP MAKE THE CALL IN PRETERM LABOR TRIAGE”

SAN FRANCISCO, CA, May 17, 2010:

Today at the Annual Meeting of The American College of Obstetricians and Gynecologists, Dr. Richard Burwick of Harbor-UCLA Medical Center in Los Angeles, CA, presented data from a new study on CerviLenz® – an innovative device used to measure vaginal cervical length in pregnant women.

The study found that a CerviLenz measurement of 30 mm was equivalent to the fetal fibronectin test (Hologic, Inc.) in predicting preterm birth in women with signs and symptoms of preterm labor. CerviLenz is a new tool that provides powerful information to help hospitals and obstetricians manage patients with suspected preterm labor.

Hospital Labor & Delivery units are often overwhelmed with cases of suspected preterm labor, but the majority of those patients will not deliver preterm. An accurate and reliable measurement of vaginal cervical length allows immediate assessment of whether delivery is imminent and helps clinicians determine what level of care is necessary. With CerviLenz, clinicians gain a quantifiable measurement and can make confident decisions faster.

CerviLenz can be used by any health care professional trained to use a speculum. Obstetricians, nursemidwives, and L&D nurses can learn how to use CerviLenz quickly and easily.

Low cost and resource efficient, CerviLenz helps save time and money while improving patient care.

CerviLenz is available for purchase now.

CerviLenz is manufactured by CerviLenz Inc. in Ohio. CerviLenz Inc. is dedicated to making a difference in the world of prematurity and donates a portion of revenue to charitable organizations advancing maternal and fetal health worldwide.

Posted on May 18, 2010 12:01 AM

© 2003-2010 Medgadget LLC. All Rights Reserved